Economics of innovation in the pharmaceutical industry

Simple item page
dc.contributor.advisorHollis, Aidan
dc.contributor.authorMoradpour Taleshi, Javad
dc.contributor.committeememberLu, Mingshan
dc.contributor.committeememberMagesan, Arvind
dc.contributor.committeememberLaliberté, Jean William P.
dc.contributor.committeememberDevlin, Rose Anne
dc.date2020-11
dc.date.accessioned2020-07-10T15:37:43Z
dc.date.available2020-07-10T15:37:43Z
dc.date.issued2020-07-06
dc.description.abstractThis thesis is a collection of three essays which investigate the economics of innovation in the healthcare industry. In Chapter 2 I use a global data set to measure the effect of health losses and average patient income on innovation in different therapeutic areas. I show that the average patient income is a strong predictor of the number of clinical trials, and I demonstrate how this can be used to identify diseases that are underfunded relative to their harm to human health. Chapter 3 presents a theoretical model of health markets with public health insurance. The model describes the operation of the cost-effectiveness threshold frequently employed by public insurers to decide which health products to cover. I show that having two different thresholds for products with and without patents can increase efficiency. Chapter 4 introduces a structural model of pharmaceutical innovation. Estimates from this model show that the net effect of a firm's innovation on their rivals' decision to innovate in the same therapeutic area is negative. The model demonstrates that previous firm-specific experience in a therapeutic area is a key factor in the decision to invest in that therapeutic area.en_US
dc.identifier.citationMoradpour Taleshi, J. (2020). Economics of innovation in the pharmaceutical industry (Doctoral thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca.en_US
dc.identifier.doihttp://dx.doi.org/10.11575/PRISM/37998
dc.identifier.urihttp://hdl.handle.net/1880/112276
dc.language.isoengen_US
dc.publisher.facultyArtsen_US
dc.publisher.institutionUniversity of Calgaryen
dc.rightsUniversity of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission.en_US
dc.subjectHealth innovationen_US
dc.subjectEmpirical industrial organizationen_US
dc.subjectPublic health insuranceen_US
dc.subjectCost-effectiveness thresholden_US
dc.subjectMarket poweren_US
dc.subjectHealth equityen_US
dc.subject.classificationEconomicsen_US
dc.subject.classificationHealth Care Managementen_US
dc.subject.classificationPublic Healthen_US
dc.titleEconomics of innovation in the pharmaceutical industryen_US
dc.typedoctoral thesisen_US
thesis.degree.disciplineEconomicsen_US
thesis.degree.grantorUniversity of Calgaryen_US
thesis.degree.nameDoctor of Philosophy (PhD)en_US
ucalgary.item.requestcopytrueen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ucalgary_2020_moradpour-taleshi_javad.pdf
Size:
737.09 KB
Format:
Adobe Portable Document Format
Description:
Thesis
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.62 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Theses and Dissertations